UBS Group
GOSS icon

UBS Group’s Gossamer Bio GOSS Stock Holding History

UBS Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$510K Buy
38,672
+15,127
+64% +$338K ﹤0.01% 6211
2026
Q1 		$620K Buy
23,545
+1,403
+6% +$176K ﹤0.01% 5918
2025
Q4 		$5.49M Sell
22,142
-12,484
-36% -$2.85M ﹤0.01% 3936
2025
Q3 		$7.29M Buy
34,626
+30,717
+786% +$5.42M ﹤0.01% 3637
2025
Q2 		$385K Buy
3,909
+1,156
+42% +$101K ﹤0.01% 6232
2025
Q1 		$242K Buy
2,753
+2,515
+1,057% +$233K ﹤0.01% 6409
2024
Q4 		$17.2K Sell
238
-1,635
-87% -$112K ﹤0.01% 7977
2024
Q3 		$148K Buy
1,873
+1,872
+187,200% +$144K ﹤0.01% 6081
2024
Q2 		$41 Sell
1
-68
-99% -$4.07K ﹤0.01% 9250
2024
Q1 		$6.52K Sell
69
-231
-77% -$20.3K ﹤0.01% 7454
2023
Q4 		$21.9K Buy
300
+275
+1,100% +$16.3K ﹤0.01% 7053
2023
Q3 		$1.67K Sell
25
-2,192
-99% -$202K ﹤0.01% 7862
2023
Q2 		$213K Buy
2,217
+42
+2% +$4.18K ﹤0.01% 5435
2023
Q1 		$219K Sell
2,175
-19,454
-90% -$2.98M ﹤0.01% 5318
2022
Q4 		$3.75M Buy
21,629
+21,243
+5,503% +$14M ﹤0.01% 2770
2022
Q3 		$370K Sell
386
-1,037
-73% -$1.03M ﹤0.01% 4591
2022
Q2 		$953K Sell
1,423
-874
-38% -$542K ﹤0.01% 3781
2022
Q1 		$1.6M Buy
2,297
+229
+11% +$177K ﹤0.01% 3652
2021
Q4 		$1.87M Buy
2,068
+1,293
+167% +$1.23M ﹤0.01% 3793
2021
Q3 		$779K Buy
775
+620
+400% +$457K ﹤0.01% 4396
2021
Q2 		$101K Sell
155
-857
-85% -$594K ﹤0.01% 5870
2021
Q1 		$749K Buy
1,012
+1,007
+20,140% +$812K ﹤0.01% 4533
2020
Q4 		$4K Buy
5
+4
+400% +$3.15K ﹤0.01% 7909
2020
Q3 		$1K Buy
+1
New +$1.06K ﹤0.01% 7790
2020
Q2 		– Sell
-51
Closed -$41K – 8099
2020
Q1 		$41K Sell
51
-318
-86% -$332K ﹤0.01% 5984
2019
Q4 		$461K Sell
369
-342
-48% -$551K ﹤0.01% 4908
2019
Q3 		$955K Buy
711
+76
+12% +$121K ﹤0.01% 4002
2019
Q2 		$1.13M Buy
+635
New +$972K ﹤0.01% 3659

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DeepCurrents Investment Group
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
Context Capital Management
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
Worth Venture Partners
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Wolverine Asset Management
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

UBS Group's GOSS Position: Q2 2026 in Review

UBS Group increased its Gossamer Bio (GOSS) stake by 64% in Q2 2026, buying an estimated $338K and bringing the position to 38,672 shares worth $510K. The position accounts for ﹤0.01% of the portfolio, ranked #6211.

UBS Group first reported a position in GOSS in Q2 2019 and has held it in 28 quarters since. The position peaked at $7.29M in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • UBS Group held 38,672 shares of Gossamer Bio worth $510K as of Q2 2026.
  • UBS Group bought 15,127 Gossamer Bio shares in Q2 2026, an estimated $338K.
  • Gossamer Bio made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6211 holding.
  • UBS Group first reported a position in Gossamer Bio in Q2 2019 and has held it in 28 quarters since.
  • UBS Group's Gossamer Bio position peaked at $7.29M in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.